Listed on GrantGunner. Last checked 15 Nov 2026.
About this grant
The support is directed at accelerating the development and deployment of clinically validated interventions targeting the root causes of multiple age-related diseases. It supports the provision of biotechnology-based interventions for healthy aging, the implementation of personalized care based on molecular phenotyping, recommendations for regulatory solutions to address aging, and improving citizens' awareness of longevity.
Who can apply
Applicants must be established in an EU member state or an associated country; a single legal entity or a consortium (for consortia, requirements regarding the number of members and countries).